Clinical Trial Update: Impact of Tegaderm HP and CHG in Major Catheter Related Infections and Dressing Detachment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Tegaderm HP dressings with chlorhexidine gluconate (CHG) for reducing major catheter-related infections and dressing detachmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheter-related Infections

Drugs mentioned

• Chlorhexidine gluconate (CHG) (chlorhexidine gluconate)
• Tegaderm HP

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Catheter-Related Infections | Phase 4 | Status: COMPLETED